• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的死亡率:一项 38 年的随访研究。

Mortality in Parkinson's disease: a 38-year follow-up study.

机构信息

Department for Neurology, Medical University Innsbruck, Austria.

出版信息

Mov Disord. 2015 Feb;30(2):266-9. doi: 10.1002/mds.26060. Epub 2014 Dec 1.

DOI:10.1002/mds.26060
PMID:25447933
Abstract

BACKGROUND

In this study we report on the outcome including overall and cause-specific mortality of Parkinson's disease (PD) patients subsequent to 38 years of surveillance. This is an extension study of our previous report on mortality.

METHODS

Two hundred thirty-seven patients with a symptom onset between 1974 and 1984 were followed until the date of December 31, 2012 or death, representing a follow-up period of up to 38 years. Overall and cause-specific standardized mortality ratios (SMRs) were calculated, and predictors for survival at disease onset were estimated.

RESULTS AND CONCLUSION

Two hundred thirty patients had died by December 31, 2012; a total of 3,489 person-years were available for observation. The SMR at 38 years of follow-up was 2.02 (1.76-2.29). Employing Cox's proportional hazard modeling, male sex, gait disorder, absence of classical rest tremor, and absence of asymmetry predicted poor survival in this cohort. Increased cause-specific SMRs were found for pneumonia and cerebrovascular and cardiovascular diseases.

摘要

背景

本研究报告了对帕金森病(PD)患者 38 年随访后全因和死因特异性死亡率的结果。这是我们之前关于死亡率研究的延伸。

方法

237 例患者于 1974 年至 1984 年间发病,随访至 2012 年 12 月 31 日或死亡,随访时间最长达 38 年。计算了全因和死因特异性标准化死亡率比(SMR),并估计了发病时生存的预测因素。

结果与结论

截至 2012 年 12 月 31 日,230 例患者死亡,共观察到 3489 人年。38 年随访的 SMR 为 2.02(1.76-2.29)。采用 Cox 比例风险模型,男性、步态障碍、无经典静止性震颤和无不对称性预测了该队列的不良预后。肺炎、脑血管和心血管疾病的死因特异性 SMR 增加。

相似文献

1
Mortality in Parkinson's disease: a 38-year follow-up study.帕金森病的死亡率:一项 38 年的随访研究。
Mov Disord. 2015 Feb;30(2):266-9. doi: 10.1002/mds.26060. Epub 2014 Dec 1.
2
Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai.中国帕金森病死亡率:上海十年随访研究结果。
Parkinsonism Relat Disord. 2018 Oct;55:75-80. doi: 10.1016/j.parkreldis.2018.05.012. Epub 2018 May 23.
3
The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up).塞戈维亚省帕金森病的自然史:一项纵向研究(20 年随访)中的死亡率。
Acta Neurol Scand. 2013 May;127(5):295-300. doi: 10.1111/ane.12003. Epub 2012 Sep 7.
4
Mortality in Parkinson's disease: a 20-year follow-up study.帕金森病的死亡率:一项20年的随访研究。
Mov Disord. 2009 Apr 30;24(6):819-25. doi: 10.1002/mds.22414.
5
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.悉尼帕金森病多中心研究:10年病程及死亡率
J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):300-7. doi: 10.1136/jnnp.67.3.300.
6
Mortality of Alzheimer's Disease Patients: A 10-Year Follow-up Pilot Study in Shanghai.阿尔茨海默病患者死亡率:上海 10 年随访试点研究。
Can J Neurol Sci. 2020 Mar;47(2):226-230. doi: 10.1017/cjn.2019.333.
7
Mortality from Parkinson's disease: a population-based prospective study (NEDICES).帕金森病死亡率:一项基于人群的前瞻性研究(NEDICES)。
Mov Disord. 2011 Dec;26(14):2522-9. doi: 10.1002/mds.23921. Epub 2011 Sep 13.
8
Mortality from Parkinson's disease in China: Findings from a five-year follow up study in Shanghai.中国帕金森病死亡率:上海一项为期五年的随访研究结果
Can J Neurol Sci. 2015 Jul;42(4):242-7. doi: 10.1017/cjn.2015.49.
9
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.英国帕金森病研究小组对早期轻度帕金森病患者联合使用左旋多巴和司来吉兰治疗时出现的超额死亡率进行的调查:随机试验和保密调查的进一步结果。
BMJ. 1998 Apr 18;316(7139):1191-6. doi: 10.1136/bmj.316.7139.1191.
10
Survival in Parkinson's disease. Relation with motor and non-motor features.帕金森病的生存率。与运动和非运动特征的关系。
Parkinsonism Relat Disord. 2014 Jun;20(6):613-6. doi: 10.1016/j.parkreldis.2014.02.030. Epub 2014 Mar 12.

引用本文的文献

1
Effects of specialised physiotherapy on mortality in Parkinson's disease: a prospective observational study.专业物理治疗对帕金森病死亡率的影响:一项前瞻性观察研究。
NPJ Parkinsons Dis. 2025 Jul 15;11(1):214. doi: 10.1038/s41531-025-01069-x.
2
Association between osteoporosis and mortality in Parkinson's disease with mediating effect of hip fractures: a Korean nationwide population-based study.帕金森病患者骨质疏松与死亡率的关联及髋部骨折的中介作用:一项基于韩国全国人口的研究
Front Aging Neurosci. 2025 May 21;17:1552381. doi: 10.3389/fnagi.2025.1552381. eCollection 2025.
3
All-Cause and Cause-Specific Mortality in Parkinson's Disease: A Meta-Analysis.
帕金森病的全因死亡率和特定病因死亡率:一项荟萃分析。
Neuroepidemiology. 2025 Apr 29:1-12. doi: 10.1159/000546136.
4
Twenty-Three-Year Mortality in Parkinson's Disease: A Population-Based Prospective Study (NEDICES).帕金森病的23年死亡率:一项基于人群的前瞻性研究(NEDICES)
J Clin Med. 2025 Jan 14;14(2):498. doi: 10.3390/jcm14020498.
5
Oral Transport, Penetration, and Aspiration in PD: Insights from a RCT on STN + SNr Stimulation.帕金森病中的口腔转运、穿透和误吸:来自一项关于丘脑底核+黑质网状部刺激的随机对照试验的见解
Dysphagia. 2024 Nov 9. doi: 10.1007/s00455-024-10779-y.
6
Seasonality as a risk factor for deaths in Parkinson's disease.季节变化作为帕金森病死亡的一个风险因素。
Clinics (Sao Paulo). 2024 Oct 25;79:100506. doi: 10.1016/j.clinsp.2024.100506. eCollection 2024.
7
Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits.在啮齿动物中模拟人类神经元儿茶酚胺色素沉着可重现与年龄相关的神经退行性缺陷。
Nat Commun. 2024 Oct 11;15(1):8819. doi: 10.1038/s41467-024-53168-7.
8
Cardiovascular outcomes in Parkinson's disease patients from a retrospective cohort study.帕金森病患者的心血管结局:一项回顾性队列研究。
Sci Rep. 2024 Sep 20;14(1):21928. doi: 10.1038/s41598-024-72549-y.
9
Validity and reliability of the Italian version of the short Parkinson's evaluation scale (SPES/SCOPA).帕金森病简短评估量表意大利语版(SPES/SCOPA)的效度和信度。
Heliyon. 2024 Jun 12;10(12):e32877. doi: 10.1016/j.heliyon.2024.e32877. eCollection 2024 Jun 30.
10
The Effect of Gut Microbiota-Targeted Interventions on Neuroinflammation and Motor Function in Parkinson's Disease Animal Models-A Systematic Review.肠道微生物群靶向干预对帕金森病动物模型神经炎症和运动功能的影响——一项系统评价
Curr Issues Mol Biol. 2024 Apr 26;46(5):3946-3974. doi: 10.3390/cimb46050244.